E-LIB Suche - Ergebnisse für: Haraldsson, Borje

1

Phase 3 trial results bring hope for patients with IgA neph..:

Haraldsson, Börje
The Lancet. 402 (2023) 10405 - p. 827-829 , 2023

Link: https://doi.org/10.1016/..

2

Six-fold increased rate of chronic kidney disease after acu..:

Cederborg, Anna ; Widman, Linnea ; Haraldsson, Borje...
Journal of Hepatology. 78 (2023) - p. S276 , 2023

Link: https://doi.org/10.1016/..

3

Tesidolumab (LFG316) for treatment of C5-variant patients w..:

Nishimura, Jun-ichi ; Ando, Kiyoshi ; Masuko, Masayoshi...
Haematologica. 107 (2022) 6 - p. 1483-1488 , 2022

Link: https://doi.org/10.3324/..

4

Proteoglycans contribute to the functional integrity of the..:

Khramova, Alina ; Boi, Roberto ; Fridén, Vincent...
Scientific Reports. 11 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

5

The Glomerular Endothelium Restricts Albumin Filtration:

Ballermann, Barbara J. ; Nyström, Jenny ; Haraldsson, Börje
Frontiers in Medicine. 8 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

6

Single-dwell treatment with a low-sodium solution in hypert..:

Davies, Simon ; Haraldsson, Börje ; Vrtovsnik, François...
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 40 (2020) 5 - p. 446-454 , 2020

Link: https://doi.org/10.1177/..

7

Small-molecule factor B inhibitor for the treatment of comp..:

Schubart, Anna ; Anderson, Karen ; Mainolfi, Nello...
Proceedings of the National Academy of Sciences of the United States of America. 116 (2019) 16 - p. 7926-7931 , 2019

Link: https://www.jstor.org/st..

8

Endothelin receptor-A mediates degradation of the glomerula..:

Ebefors, Kerstin ; Wiener, Robert J. ; Yu, Liping...
Kidney International. 96 (2019) 4 - p. 957-970 , 2019

Link: https://doi.org/10.1016/..

9

Small-molecule factor B inhibitor for the treatment of comp..:

Schubart, Anna ; Anderson, Karen ; Mainolfi, Nello...
Proceedings of the National Academy of Sciences. 116 (2019) 16 - p. 7926-7931 , 2019

Link: https://doi.org/10.1073/..

10

Patients' Perceptions and Factors Affecting Dialysis Modali..:

Friberg, Ingrid O. ; Mårtensson, Lena ; Haraldsson, Börje...
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 38 (2018) 5 - p. 334-342 , 2018

Link: https://doi.org/10.3747/..

11

Amplification of the Melanocortin-1 Receptor in Nephrotic S..:

Bergwall, Lovisa ; Wallentin, Hanna ; Elvin, Johannes...
Scientific Reports. 8 (2018) 1 - p. , 2018

Link: https://doi.org/10.1038/..

12

Pharmacokinetic Properties of the Nephrotoxin Orellanine in..:

Najar, Deman ; Haraldsson, Börje ; Thorsell, Annika...
Toxins. 10 (2018) 8 - p. 333 , 2018

Link: https://doi.org/10.3390/..

13

Orellanine specifically targets renal clear cell carcinoma:

Buvall, Lisa ; Hedman, Heidi ; Khramova, Alina...
Oncotarget. 8 (2017) 53 - p. 91085-91098 , 2017

Link: https://doi.org/10.18632..

14

Long-term clinical outcome for patients poisoned by the fun..:

Hedman, Heidi ; Holmdahl, Johan ; Mölne, Johan...
BMC Nephrology. 18 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

15

Treatment pattern in patients with idiopathic membranous ne..:

Lönnbro-Widgren, Jennie ; Mölne, Johan ; Haraldsson, Börje.
Clinical Kidney Journal. 9 (2016) 2 - p. 227-233 , 2016

Link: https://doi.org/10.1093/..